{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:53:55Z","timestamp":1761630835175,"version":"3.40.5"},"reference-count":42,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.humimm.2018.08.008","type":"journal-article","created":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T10:29:11Z","timestamp":1534501751000},"page":"865-868","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Minimal data reporting standards for serological testing for histocompatibility"],"prefix":"10.1016","volume":"79","author":[{"given":"Nicole M.","family":"Valenzuela","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Medhat","family":"Askar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastiaan","family":"Heidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Jindra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4199-3435","authenticated-orcid":false,"given":"Abeer","family":"Madbouly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4827-6885","authenticated-orcid":false,"given":"David","family":"Pinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2648-2944","authenticated-orcid":false,"given":"Annette","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis G.","family":"Hidalgo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.humimm.2018.08.008_b0005","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/ndt\/gfr429","article-title":"Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation","volume":"27","author":"Caro-Oleas","year":"2012","journal-title":"Nephrol. Dial Transplant."},{"issue":"6","key":"10.1016\/j.humimm.2018.08.008_b0010","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/TP.0000000000000511","article-title":"Characteristics of circulating donor human leukocyte antigen-specific immunoglobulin g antibodies predictive of acute antibody-mediated rejection and kidney allograft failure","volume":"99","author":"Kannabhiran","year":"2015","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.humimm.2018.08.008_b0015","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"issue":"13","key":"10.1016\/j.humimm.2018.08.008_b0020","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.humimm.2018.08.008_b0025","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1097\/TP.0000000000000191","article-title":"Pretransplant immunologic risk assessment of kidney transplant recipients with donor-specific anti-human leukocyte antigen antibodies","volume":"98","author":"Marfo","year":"2014","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.humimm.2018.08.008_b0030","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1600-6143.2006.01721.x","article-title":"The importance of anti-HLA-specific antibody strength in monitoring kidney transplant patients","volume":"7","author":"Mizutani","year":"2007","journal-title":"Am. J. Transplant"},{"issue":"2","key":"10.1016\/j.humimm.2018.08.008_b0035","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1681\/ASN.2013101144","article-title":"Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss","volume":"26","author":"Sicard","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/j.humimm.2018.08.008_b0040","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1432-2277.2009.00912.x","article-title":"Clinical relevance of preformed C4d-fixing and non-C4d-fixing HLA single antigen reactivity in renal allograft recipients","volume":"22","author":"Wahrmann","year":"2009","journal-title":"Transpl. Int."},{"issue":"1","key":"10.1016\/j.humimm.2018.08.008_b0045","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.healun.2012.09.021","article-title":"Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients","volume":"32","author":"Zeevi","year":"2013","journal-title":"J. Heart Lung Transplant"},{"issue":"9","key":"10.1016\/j.humimm.2018.08.008_b0050","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1111\/trf.12064","article-title":"Lot-to-lot variability in HLA antibody screening using a multiplexed bead-based assay","volume":"53","author":"Gandhi","year":"2013","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.humimm.2018.08.008_b0055","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/tan.12860","article-title":"How can we reduce costs of solid-phase multiplex-bead assays used to determine anti-HLA antibodies?","volume":"88","author":"Kamburova","year":"2016","journal-title":"HLA"},{"issue":"11","key":"10.1016\/j.humimm.2018.08.008_b0060","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1111\/ajt.12463","article-title":"Solid-phase bead-based assays limitations are not restricted to interlaboratory variability","volume":"13","author":"Maillard","year":"2013","journal-title":"Am. J. Transplant"},{"issue":"11","key":"10.1016\/j.humimm.2018.08.008_b0065","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1111\/ajt.12462","article-title":"Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA-drilling down on key sources of variation","volume":"13","author":"Reed","year":"2013","journal-title":"Am. J. Transplant"},{"issue":"7","key":"10.1016\/j.humimm.2018.08.008_b0070","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/ajt.12287","article-title":"Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA","volume":"13","author":"Reed","year":"2013","journal-title":"Am. J. Transplant"},{"issue":"7","key":"10.1016\/j.humimm.2018.08.008_b0075","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.humimm.2009.04.001","article-title":"Naturally occurring interference in Luminex assays for HLA-specific antibodies: characteristics and resolution","volume":"70","author":"Zachary","year":"2009","journal-title":"Hum Immunol."},{"issue":"5","key":"10.1016\/j.humimm.2018.08.008_b0080","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/TP.0b013e31822872dd","article-title":"HLA antibody specification using single-antigen beads \u2013 a technical solution for the prozone effect","volume":"92","author":"Schnaidt","year":"2011","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.humimm.2018.08.008_b0085","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1744-313X.2012.01147.x","article-title":"The complement-mediated prozone effect in the Luminex single-antigen bead assay and its impact on HLA antibody determination in patient sera","volume":"40","author":"Weinstock","year":"2013","journal-title":"Int. J. Immunogenet."},{"issue":"11","key":"10.1016\/j.humimm.2018.08.008_b0090","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.humimm.2016.02.008","article-title":"Deciphering IgM interference in IgG anti-HLA antibody detection with flow beads assays","volume":"77","author":"Visentin","year":"2016","journal-title":"Hum. Immunol."},{"issue":"11\u201312","key":"10.1016\/j.humimm.2018.08.008_b0095","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.humimm.2017.09.001","article-title":"Comprehensive assessment for serum treatment for single antigen test for detection of HLA antibodies","volume":"78","author":"Zhang","year":"2017","journal-title":"Hum. Immunol."},{"issue":"9","key":"10.1016\/j.humimm.2018.08.008_b0100","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1111\/ajt.12807","article-title":"HLA antibody detection with solid phase assays: great expectations or expectations too great?","volume":"14","author":"Gebel","year":"2014","journal-title":"Am. J. Transplant"},{"issue":"11","key":"10.1016\/j.humimm.2018.08.008_b0105","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000000734","article-title":"Comparative assessment of anti-HLA antibodies using two commercially available Luminex-based assays","volume":"3","author":"Clerkin","year":"2017","journal-title":"Transplant Direct."},{"issue":"5","key":"10.1016\/j.humimm.2018.08.008_b0110","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/TP.0b013e31820794bb","article-title":"Interpretation of positive flow cytometric crossmatch in the era of the single-antigen bead assay","volume":"91","author":"Couzi","year":"2011","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.humimm.2018.08.008_b0115","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.humimm.2010.01.003","article-title":"Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: a 30-month analysis in living donor kidney transplantation","volume":"71","author":"Morris","year":"2010","journal-title":"Hum. Immunol."},{"issue":"7","key":"10.1016\/j.humimm.2018.08.008_b0120","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/TP.0000000000000229","article-title":"Denatured class I human leukocyte antigen antibodies in sensitized kidney recipients: prevalence, relevance, and impact on organ allocation","volume":"98","author":"Visentin","year":"2014","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.humimm.2018.08.008_b0125","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/TP.0b013e3182612967","article-title":"High transplant rates of highly sensitized recipients with virtual crossmatching in kidney paired donation","volume":"94","author":"Ferrari","year":"2012","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.humimm.2018.08.008_b0130","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/ki.2014.106","article-title":"Impact of donor mismatches at individual HLA-A, -B, -C, -DR, and -DQ loci on the development of HLA-specific antibodies in patients listed for repeat renal transplantation","volume":"86","author":"Kosmoliaptsis","year":"2014","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.humimm.2018.08.008_b0135","article-title":"Significance of anti-HLA antibodies on adult and pediatric heart allograft outcomes","volume":"8","author":"Mangiola","year":"2017","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.humimm.2018.08.008_b0140","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.humimm.2016.04.010","article-title":"Clinically-relevant threshold of preformed donor-specific anti-HLA antibodies in kidney transplantation","volume":"77","author":"Salvade","year":"2016","journal-title":"Hum. Immunol."},{"issue":"3","key":"10.1016\/j.humimm.2018.08.008_b0145","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.kint.2017.03.033","article-title":"Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis","volume":"92","author":"Gosset","year":"2017","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.humimm.2018.08.008_b0150","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1681\/ASN.2017050589","article-title":"Complement-activating anti-HLA antibodies in kidney transplantation: allograft gene expression profiling and response to treatment","volume":"29","author":"Lefaucheur","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.humimm.2018.08.008_b0155","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1681\/ASN.2016030368","article-title":"Value of donor-specific anti-HLA antibody monitoring and characterization for risk stratification of kidney allograft loss","volume":"28","author":"Viglietti","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.humimm.2018.08.008_b0160","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.14695","article-title":"Study rationale, design, and pretransplantation alloantibody status: a first report of Clinical Trials in Organ Transplantation in Children-04 (CTOTC-04) in pediatric heart transplantation","author":"Zuckerman","year":"2018","journal-title":"Am. J. Transplant."},{"issue":"6","key":"10.1016\/j.humimm.2018.08.008_b0165","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/ajt.14229","article-title":"The road to HLA antibody evaluation: do not rely on MFI","volume":"17","author":"Sullivan","year":"2017","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.humimm.2018.08.008_b0170","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","article-title":"Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation","volume":"95","author":"Tait","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2018.08.008_b0175","first-page":"295","article-title":"Epitopes of HLA-A, B, C, DR, DQ, DP and MICA antigens","author":"El-Awar","year":"2009","journal-title":"Clin. Transpl."},{"issue":"3","key":"10.1016\/j.humimm.2018.08.008_b0180","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/tan.12390","article-title":"Validation of statistical imputation of allele-level multilocus phased genotypes from ambiguous HLA assignments","volume":"84","author":"Madbouly","year":"2014","journal-title":"Tissue Antigens"},{"issue":"10","key":"10.1016\/j.humimm.2018.08.008_b0185","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.humimm.2013.06.025","article-title":"Six-locus high resolution HLA haplotype frequencies derived from mixed-resolution DNA typing for the entire US donor registry","volume":"74","author":"Gragert","year":"2013","journal-title":"Hum. Immunol."},{"issue":"7","key":"10.1016\/j.humimm.2018.08.008_b0190","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1111\/ajt.14752","article-title":"Sensitization in transplantation: assessment of risk (STAR) 2017 working group meeting report","volume":"18","author":"Tambur","year":"2018","journal-title":"Am. J. Transplant."},{"issue":"5","key":"10.1016\/j.humimm.2018.08.008_b0195","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1399-0039.2011.01777.x","article-title":"A community standard for immunogenomic data reporting and analysis: proposal for a STrengthening the REporting of Immunogenomic Studies statement","volume":"78","author":"Hollenbach","year":"2011","journal-title":"Tissue Antigens"},{"issue":"12","key":"10.1016\/j.humimm.2018.08.008_b0200","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.humimm.2015.09.011","article-title":"Minimum information for reporting next generation sequence genotyping (MIRING): guidelines for reporting HLA and KIR genotyping via next generation sequencing","volume":"76","author":"Mack","year":"2015","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2018.08.008_b0205","doi-asserted-by":"crossref","first-page":"1652931","DOI":"10.1155\/2017\/1652931","article-title":"Renal transplant patients biopsied for cause and tested for C4d, DSA, and IgG subclasses and C1q: which humoral markers improve diagnosis and outcomes?","volume":"2017","author":"Cicciarelli","year":"2017","journal-title":"J. Immunol. Res."},{"issue":"2","key":"10.1016\/j.humimm.2018.08.008_b0210","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/TP.0000000000000220","article-title":"Epitope analysis of HLA-DQ antigens: what does the antibody see?","volume":"98","author":"Tambur","year":"2014","journal-title":"Transplantation"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885918305196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885918305196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T19:34:40Z","timestamp":1543433680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885918305196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0198885918305196"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2018.08.008","relation":{},"ISSN":["0198-8859"],"issn-type":[{"type":"print","value":"0198-8859"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minimal data reporting standards for serological testing for histocompatibility","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2018.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc. on behalf of American Society for Histocompatibility and Immunogenetics.","name":"copyright","label":"Copyright"}]}}